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Abstract
A 13-year-old boy with no risk factors for lung cancer presented with a massive left-sided pleural effusion and a
mediastinal shift on chest radiography and computed tomography. A chest tube drained bloody pleural fluid with an
exudative pattern. A pleural biopsy and wedge biopsy of the left lower lobe revealed mucinous adenocarcinoma in the
left lower lobe wedge biopsy and metastatic adenocarcinoma in the pleural biopsy. The patient is currently undergoing
chemotherapy. Radiotherapy is planned after shrinkage of the tumor. Adenocarcinoma of the lung is very rarely seen in
teenagers or children, especially in the absence of risk factors.
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Introduction
Adenocarcinoma of the lung arises from atypical aden-
omatous hyperplasia progressing to bronchioloalveolar
carcinoma which then transforms into invasive adeno-
carcinoma. This tumor is the most common type of
lung cancer in women and nonsmokers, but the average
age of patients is 45 years, and it is very rarely seen in
teenagers or children.1,2 The prognosis of primary
adenocarcinoma in adults and children is equally
poor.3 There is a strong relationship between risk fac-
tors (smoking, underlying infections, air pollution, gen-
etic) and adenocarcinoma, but in rare cases, none of
these risk factors are detected.
Case report
A 13-year-old boy, who was treated for cough, coryza,
chills and fever for one month with a poor response to
medical therapy, presented with a massive left-sided
pleural eﬀusion and a mediastinal shift on chest radi-
ography and computed tomography (Figure 1). He had
no history of trauma or family history of cancer, and he
was not an active or passive smoker. He was tachypneic
(28 breathsmin1) but afebrile. On physical examin-
ation, respiratory sounds were absent on the left side.
A chest tube as inserted and he was transferred to the
intensive care unit. Because of unilateral bloody pleural
ﬂuid with an exudative pattern (Table 1), thoracoscopy
was performed via a camera inserted into the chest tube
hole. We observed a hepatized lung with severe pleural
inﬂammation, thus a lateral minithoracotomy was per-
formed for pleural biopsy and wedge biopsy of the left
lower lobe (Figure 2). Pathology revealed mucinous
adenocarcinoma in the left lower lobe wedge biopsy
and metastatic adenocarcinoma in the pleural biopsy
(Figure 3). Because of the family’s low economic
status, we could not perform immunohistochemistry.
Smear and culture of the pleural ﬂuid were negative
for tuberculosis. Cytology of the pleural ﬂuid was
Asian Cardiovascular & Thoracic Annals
0(0) 1–4
 The Author(s) 2016
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0218492316633011
aan.sagepub.com
1Department of Surgery, 5 Azar Hospital, Golestan University of Medical
Sciences, Gorgan, Iran
2Department of Pathology, 5 Azar Hospital, Golestan University of
Medical Sciences, Gorgan, Iran
3Clinical Research Development Unit (CRDU), 5 Azar Hospital, Golestan
University of Medical Sciences, Gorgan, Iran
Corresponding author:
Reza Afghani, Department of Surgery, 5 Azar Hospital, Golestan
University of Medical Sciences, Gorgan, Iran.
Email: af_med75@yahoo.com
 by guest on February 10, 2016aan.sagepub.comDownloaded from 
positive for malignancy. Some tumor markers were
elevated (Table 2). Fiberoptic bronchoscopy after
expansion of the lung showed no endobronchial
lesion. Metastatic evaluations, including brain and
abdominopelvic computed tomography and a bone
scan, were negative. Chemotherapy with cisplatin and
gemcitabine was started. The patient has completed
the 4th course and 2 additional courses remain.
Radiotherapy is our next plan after shrinkage of the
tumor. So far, his condition is good and the response
to treatment is acceptable.
Discussion
Primary pulmonary neoplasms are extremely rare in
children, and metastatic tumors of nonpulmonary
origin (osteogenic sarcoma, Wilms tumor, and rhabdo-
myosarcoma) are more prevalent than primary lung
cancers.4 Benign tumors constitute the majority of pri-
mary pulmonary neoplasms. The clinical presentation
of lung cancer includes local symptoms that can be
bronchopulmonary, non-bronchopulmonary, or from
metastatic disease, and may also be due to paraneoplas-
tic syndrome.5 Symptoms can mimic a common cold or
pneumonia, and chest radiographs may be similar to
pneumonia consolidation of the lung.6 In every patient
who receives medication for pneumonia, the diagnosis
should be established by chest radiography. Recurrent
pneumonia and failure to improve with medical treat-
ment should raise suspicion of underlying problems
such as malignancy.1 The prognosis for primary malig-
nancy in children is best for endocrine or mucoepider-
moid tumors, but as in adults, the outcome for
adenocarcinoma is poor, especially in patients with
metastatic disease where surgery is excluded from mul-
timodality therapy. Primary lung adenocarcinoma in
children frequently presents as metastatic disease at
diagnosis, and the median survival is 6–9 months.7,8
Immunohistochemistry can help to conﬁrm the lung
as the primary source of metastatic adenocarcinoma. In
our patient, because of the family’s economic status, we
could not perform positron-emission tomography for
Figure 1. (a) Chest radiograph, (b) conventional computed tomography (mediastinal view), and (c) high-resolution computed
tomography (parenchymal view) before chest tube insertion.
Table 1. Pleural fluid analysis.
Variable Pleural fluid Serum
Glucose (gdL1) 76 97
Protein (gdL1) 4.6 6.5
Albumin (gdL1) 3.5 5
Lactic dehydrogenase (UL1) 384 517
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staging, immunohistochemistry for deﬁnite diagnosis,
or molecular testing to establish the histologic subtype
and decide systemic therapy. We started 6 courses of
gemcitabine (1000mgm2day1 on days 1 and 8) plus
cisplatin (75mgm2day1 on day 1) with a week
between courses. At the end of 4th course, the tumor
Figure 2. (a) Chest radiograph, (b) parenchymal view of the left upper lobe, (c) mediastinal view of the left lower lobe, and
(d) parenchymal view of the left lower lobe after thoracotomy.
Figure 3. Pathology revealing a mucinous adenocarcinoma:
hyperchromic nuclei with mitosis and atypia. Hematoxylin and
eosin stain, original magnification 40.
Table 2. Serum tumor markers.
Tumor marker Value Normal range
Carcinoembryonic antigen 13.1 3.5–5
Carbohydrate antigen 19-9 318.4 0–35
Beta-human chorionic gonadotropin 1.5 0–15
Alpha fetoprotein 1 0.2–8.8
Beta-2 microglobulin 1.1 43
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response to chemotherapy was acceptable. More
follow-up after completion of treatment is needed to
document ﬁnal survival.
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